Invasive Fungal Infections after CD19 CAR T-cell Therapy for B-Cell Lymphoma: a LYSA study from the DESCAR-T Registry.

Fiche publication

Date publication

octobre 2025

Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Dr CASASNOVAS Olivier

Tous les auteurs :
Bouvier A, Durand A, Dupont V, Gower N, Castilla Lorente C, Campidelli A, Dulery R, Gangneux JP, Joris M, Eloit M, Latiere C, di Blasi R, Denis B, Gabellier L, Morschhauser F, Casasnovas O, Houot R, Angebault C, Bachy E, Le Bras F, Gastinne T, Tudesq JJ, Lemonnier F, Melica G

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41109429

Résumé

To describe the landscape of IFI after chimeric antigen receptor (CAR) T-cell therapy for B-cell malignancies from the French national DESCAR-T registry and evaluate risk factors associated with invasive fungal infections (IFI) in this population.